Search Results 81-90 of 14488 for Lupus
Safety, Efficacy And Tolerability Of Ianalumab Versus Placebo, Combination With SoC Therapy, In Participants With Active Lupus Nephritis · More about research at ...
Clinical Trials · RESET-SLE: A Phase 1/2 Open-Label Study To Evaluate The Safety And Efficacy Of CABA-201 In Subjects With Active Systemic Lupus Erythematosus.
Anifrolumab-fnia injection is used to treat moderate to severe systemic lupus erythematosus (SLE) in patients who are also receiving other lupus treatments.
Diagnosis of discoid/subacute cutaneous lupus erythematosus (DLE/SCLE) for at least 3 months prior to screening visit. · Meets both clinical and ...
Other autoimmune conditions, such as lupus, rheumatoid arthritis, scleroderma and Sjogren syndrome, can happen with polymyositis. Cardiovascular disease ...
Lupus. A lasting condition, systemic lupus erythematosus can inflame many parts of the body. These include the skin, joints, kidneys, blood cells, heart and ...
Lupus rash. Lupus is an inflammatory disorder that affects a number of body systems. One symptom is the appearance of a bumpy rash on skin exposed to ...
This observational study is a registry designed to assess the utilization and effectiveness of LUPKYNIS in adult patients with lupus nephritis (LN) in the ...
The purpose of this study is to test the hypothesis that subjects with active System Lupus Erythematosus (SLE) will benefit from correcting their omega-3 ...
The purpose of this study is to evaluate the effectiveness and safety of deucravacitinib compared with placebo in an active moderate to severe Systemic Lupus ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.